ClinConnect ClinConnect Logo
Search / Trial NCT06172504

Ejaculation Frequency and Semen Parameters

Launched by THE FIRST HOSPITAL OF JILIN UNIVERSITY · Dec 14, 2023

Trial Information

Current as of July 25, 2025

Recruiting

Keywords

Semen Parameters Ejaculation Frequency The Penultimate Abstinence Period

ClinConnect Summary

This clinical trial, titled "Ejaculation Frequency and Semen Parameters," is studying how the frequency of ejaculation affects men's semen quality, which is important for fertility. The researchers want to find out if how often men ejaculate and the length of time they abstain from ejaculation before a semen test can impact the results. The study is taking place at the Reproductive Center of the First Hospital of Jilin University, where men between the ages of 22 and 45 with normal ejaculation function can participate.

To join the trial, men should be generally healthy and able to ejaculate normally. The study will involve a brief medical history, including details about their overall health and fertility. Participants can expect to provide semen samples after different periods of abstinence, which will help the researchers gather information about how ejaculation frequency may relate to semen quality. It's important to note that men with severe sperm issues or certain health conditions will not be eligible for this study. If you're looking to understand how ejaculation frequency affects fertility, this trial may offer valuable insights.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. Normal ejaculation function, normal sexual life, masturbation can ejaculate
  • 2. Male age between 22 and 45 years old.
  • 3. According to World Health Organization standards, the semen examination time is within 48h to 7 days of abstinence.
  • Exclusion Criteria:
  • 1. The man was diagnosed with extremely severe oligospermia (sperm concentration \<1 million/ml) and azoospermia.
  • 2. Identify the factors affecting semen parameters, long-term exposure to high temperature, long-term exposure to chemicals, heavy metals, radiation and other toxic and harmful substances, orchitis/epididymitis, cryptorchidism, radiotherapy and chemotherapy treatment, and taking drugs to improve sperm within three months

About The First Hospital Of Jilin University

The First Hospital of Jilin University is a prestigious academic medical center located in Changchun, China, dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a leading institution in medical education and research, the hospital actively engages in a wide range of clinical trials aimed at improving treatment outcomes and enhancing patient safety across various specialties. With a commitment to excellence, the First Hospital collaborates with multidisciplinary teams of healthcare professionals, leveraging cutting-edge technologies and methodologies to contribute to the global body of medical knowledge.

Locations

Changchun, Jilin, China

Patients applied

0 patients applied

Trial Officials

yang yu

Principal Investigator

The First Hospital of Jilin University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported